Search research articles
Contact Us
Filters
Showing results (61-70 of 89) with videos related to
Page
of 9
Sort By:
BMC Medical Informatics and Decision Making
|
April 1, 2025
Development and multicentric external validation of a prognostic COVID-19 severity model based on thoracic CT
Ine Dirks, Matías Nicolás Bossa, Abel Díaz Berenguer, et al.
Plos One
|
November 28, 2022
Increased KL-6 levels in moderate to severe COVID-19 infection
Maureen Cambier, Monique Henket, Anne Noelle Frix, et al.
Frontiers in Immunology
|
October 16, 2025
Personalized prediction of SARS-CoV-2 vaccine-induced immunity after boost: a longitudinal analysis using joint modeling
Iraklis Papadopoulos, Anh Nguyet Diep, Joey Schyns, et al.
BMC Infectious Diseases
|
December 3, 2022
Impact of COVID-19 on the Belgian HIV epidemic: slowdown of HIV transmission and testing and adaptation of care
Dominique Van Beckhoven, Ben Serrien, Marion Montourcy, et al.
Research Square
|
May 22, 2023
Early Elevated IFNα Identified as the Key Mediator of HIV Pathogenesis and its low level a Hallmark of Elite Controllers
Hélène Le Buanec, Valérie Schiavon, Marine Merandet, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Doubling dolutegravir dosage reduces the viral reservoir in ART-treated people with HIV
Céline Fombellida-Lopez, Aurelija Valaitienė, Lee Winchester, et al.
Research Square
|
May 22, 2023
IFNα induces CCR5 in CD4<sup>+</sup> T-cells, causing its anti- HIV inefficiency and its subsequent pathogenic elevation, partially controlled by anti-HIV therapy
Hélène Le Buanec, Valérie Schiavon, Marine Merandet, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
July 17, 2021
Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study
Gilles Darcis, Antoine Bouquegneau, Nathalie Maes, et al.
Elife
|
January 23, 2026
Doubling dolutegravir dosage reduces the viral reservoir in ART-treated people with HIV
Céline Fombellida-Lopez, Aurelija Valaitienė, Lee Winchester, et al.
Communications Medicine
|
March 20, 2024
Early elevated IFNα is a key mediator of HIV pathogenesis
Hélène Le Buanec, Valérie Schiavon, Marine Merandet, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 89) with videos related to
Sort By:
Page
of 9
BMC Medical Informatics and Decision Making
|
April 1, 2025
Development and multicentric external validation of a prognostic COVID-19 severity model based on thoracic CT
Ine Dirks, Matías Nicolás Bossa, Abel Díaz Berenguer, et al.
Plos One
|
November 28, 2022
Increased KL-6 levels in moderate to severe COVID-19 infection
Maureen Cambier, Monique Henket, Anne Noelle Frix, et al.
Frontiers in Immunology
|
October 16, 2025
Personalized prediction of SARS-CoV-2 vaccine-induced immunity after boost: a longitudinal analysis using joint modeling
Iraklis Papadopoulos, Anh Nguyet Diep, Joey Schyns, et al.
BMC Infectious Diseases
|
December 3, 2022
Impact of COVID-19 on the Belgian HIV epidemic: slowdown of HIV transmission and testing and adaptation of care
Dominique Van Beckhoven, Ben Serrien, Marion Montourcy, et al.
Research Square
|
May 22, 2023
Early Elevated IFNα Identified as the Key Mediator of HIV Pathogenesis and its low level a Hallmark of Elite Controllers
Hélène Le Buanec, Valérie Schiavon, Marine Merandet, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Doubling dolutegravir dosage reduces the viral reservoir in ART-treated people with HIV
Céline Fombellida-Lopez, Aurelija Valaitienė, Lee Winchester, et al.
Research Square
|
May 22, 2023
IFNα induces CCR5 in CD4<sup>+</sup> T-cells, causing its anti- HIV inefficiency and its subsequent pathogenic elevation, partially controlled by anti-HIV therapy
Hélène Le Buanec, Valérie Schiavon, Marine Merandet, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
July 17, 2021
Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study
Gilles Darcis, Antoine Bouquegneau, Nathalie Maes, et al.
Elife
|
January 23, 2026
Doubling dolutegravir dosage reduces the viral reservoir in ART-treated people with HIV
Céline Fombellida-Lopez, Aurelija Valaitienė, Lee Winchester, et al.
Communications Medicine
|
March 20, 2024
Early elevated IFNα is a key mediator of HIV pathogenesis
Hélène Le Buanec, Valérie Schiavon, Marine Merandet, et al.
Page
of 9